Latest Peptide Wire
TGA Alert Follows Counterfeit Retatrutide Vial Containing Eightfold Semaglutide Dose
Biodexa Reports £1.84 Million Loss for First Half of 2026
Gan&Lee doses first patient in Phase 1 trial of GZC8072 oral GLP-1 receptor agonist
Eli Lilly Directs GLP-1 Revenue Toward Bone Health and Endometriosis Pipeline Expansion

Centric Compounding Recalls Six Injectable Lots After Endotoxin Reports
An FDA-posted recall covers six lots of glutathione, Myer's Cocktail and Tri-Immune Boost injections. Patients and clinics should check the affected products.
Deep Dives

BPC-157 Use Rose Sharply in Medical Records, but Safety Answers Lag
A new retrospective preprint counts 1,039 patients with documented BPC-157 use, offering a rare measure of demand while leaving clinical outcomes unresolved.

Hannah Waddingham Fronts Paula’s Choice Peptide Moisturizer Campaign
Hannah Waddingham is fronting the launch campaign for Paula’s Choice Pro-Collagen Peptide Plumping Intensive Moisturizer. The product uses three peptides, but its evidence remains product-specific.
Clinical Monographs & Research Tools
Clinical Peptides Library
Comprehensive monographs covering Semaglutide, Tirzepatide, BPC-157, Retatrutide, and GHRH secretagogues with FDA approval status and human clinical trial data.
FDA Approval Status Checker
Instant searchable engine verifying FDA drug approvals, 503A Category 1/2 bulk compounding restrictions, and WADA anti-doping classifications.
Serum Decay & PK Plotter
Interactive 1-compartment pharmacokinetic simulation engine for multi-compound blood serum curves, half-lives, and steady-state plateaus.
Research Guides & Protocols

Cell Penetrating Peptide Database Access and Curated Records
CPPsite 2.0 and POSEIDON hold the primary public records for cell-penetrating peptide sequences. Neither database functions as a regulatory standard or FDA pre-market clearance mechanism.

Cosmetic Peptide Safety Assessment: How the CIR Evaluates INCI Ingredients
The Cosmetic Ingredient Review panel evaluates peptide safety for topical use based on INCI nomenclature, concentration thresholds, and exposure route. This assessment framework is distinct from drug approval.

Hydrolyzed Collagen Vs Collagen Peptides
Hydrolyzed collagen and collagen peptides represent the same manufactured substance. The distinction exists only in labeling convention, not statutory classification or chemical structure.

NeoCell Bio-Peptides: Trademark Claims and Dietary Supplement Labeling
NeoCell Collagen Bio-Peptides is a trademarked manufacturing designation for hydrolyzed collagen. Commercial labeling and retail distribution records document the composition and sourcing inputs.

Peptide Purity Testing Cost: Commercial Rates and Procurement Benchmarks
Third-party peptide purity testing costs range from $200 for standalone HPLC analysis to $5,000 for regulatory-grade characterization. This reference documents published service rates and the analytical variables that determine procurement.

Bioactive Peptides: Regulatory Classification and Evidentiary Thresholds
An FDA advisory committee recommendation separates bioactive peptides into approved therapeutics and unapproved compounds. Preclinical evidence dominates the unapproved category.
Newsroom Analysis & Industry Wire
Trending Coverage
The Agora Scientific Forums
Join peer researchers, clinicians, and analytical chemists in open, moderated scientific discussions regarding HPLC lab verification, testing methods, and peptide research.






